Vanilloid receptor 1 (VR1), a capsaicin receptor, is known to play a major role in mediating inflammatory thermal nociception. Although the physiological role and biophysical properties of VR1 are known, the mechanism of its activation by ligands is poorly understood. Here we show that VR1 must be phosphorylated by Ca 2؉ -calmodulin dependent kinase II (CaMKII) before its activation by capsaicin. In contrast, the dephosphorylation of VR1 by calcineurin leads to a desensitization of the receptor. Moreover, point mutations in VR1 at two putative consensus sites for CaMKII failed to elicit capsaicin-sensitive currents and caused a concomitant reduction in VR1 phosphorylation in vivo. Such mutants also lost their high affinity binding with [ 3 H]resiniferatoxin, a potent capsaicin receptor agonist. We conclude that the dynamic balance between the phosphorylation and dephosphorylation of the VR1 channel by CaMKII and calcineurin, respectively, controls the activation/ desensitization states by regulating VR1 binding. Furthermore, because sensitization by protein kinase A and C converge at these sites, phosphorylation stress in the cell appears to control a wide range of excitabilities in response to various adverse stimuli.
Vanilloid receptor 1 (VR1) 1 encodes a ligand-gated, cationic channel that is activated by capsaicin, the potent pain-causing principal of hot chili peppers (1) . VR1 belongs to TRPV, a subset of TRP channel family; members of TRP channels are typified by having six transmembrane domains and ankyrin repeats at the N terminus (2) . As are other channel members of the TRPV family (3), VR1 is activated by heat and extracellular acid (1, 4) . In much the same way as morphine receptors, researchers have tried to identify the endogenous activators of VR1, and as a result, 12-hydroperoxytetraenoic acid, a product of 12-lipoxygenase, was identified to activate VR1, to bind VR1, and to share structural similarity with capsaicin (5, 6) . Interestingly, anandamide and other endocannabinoids also activate VR1 (7) . Bradykinin, a potent algogenic inflammatory mediator, is now known to activate VR1 via protein kinase C (PKC), phosphatidylinositol-4,5-bisphosphate, or lipoxygenasedependent pathways (6, 8, 9) , suggesting that VR1 has a role in the mediation of inflammatory pain. More direct evidence of the pathophysiological role of VR1 resulted from knock-out experiments, because thermal hyperalgesia induced by inflammation was reduced in mice lacking VR1 (10, 11) . Thus, VR1 is believed to be a key element in the generation of nociceptive neural signals in sensory neurons.
Mutational studies have localized the regions of VR1 responsible for vanilloid binding. Using a chimeric construction with avian VR1, Jordt and Julius (12) find that transmembrane domain III and its vicinity are responsible for hydrophobic interactions with vanilloids. In addition, two individual sites in the N and C termini are known to be critical for the hydrophilic binding of vanilloids (13) . Even though specific regions for ligand binding are now known, the gating mechanisms of VR1 facilitated by vanilloids are largely unknown.
Sensory neurons become unresponsive to capsaicin after repeated or prolonged capsaicin application (14) , because the capsaicin-activated current or Ca 2ϩ influx in sensory neurons desensitizes after prolonged or repeated exposure to capsaicin (15) (16) (17) . Because of their desensitizing effect on sensory neurons, capsaicin or its analogs are often used as analgesics (18, 19) . The desensitization of capsaicin-evoked currents is dependent on external Ca 2ϩ and presumably upon the activity of a Ca 2ϩ -dependent phosphatase (16, 17) . Recently, Bhave et al. (20) suggested that protein kinase A (PKA) controls tachyphylaxis, the reduced response to repeated stimuli. However, the molecular mechanism of VR1 desensitization has remained elusive. Therefore, we sought to identify the molecular events that lead to the desensitization of VR1, and during the course of this investigation we found the mode of activation of VR1 by vanilloids.
EXPERIMENTAL PROCEDURES
Primary Cultures and Single-channel Recording-Primary cultures of sensory neurons isolated from all levels of the dorsal root ganglions of neonatal rats were prepared as previously described (5, 21) . A standard patch clamp technique was used to record single-channel currents in cultured sensory neurons (22) . Pipette and control bath solutions contained 130 mM NaCl, 2 mM MgCl 2 , 5 mM KCl, 2 mM Ca 2ϩ , and 10 mM NaOH/HEPES and were adjusted to pH 7.2. In the Ca 2ϩ -free condition, the bath solution contained 130 mM NaCl, 2 mM MgCl 2 , 5 mM KCl, 5 mM EGTA, and 10 mM NaOH/HEPES (pH 7.2). All recordings were made at room temperature. Borosilicate glass pipettes (World Precision Instruments, Saratoga, FL) were pulled to a tip resistance of 2 megaohms. The glass pipettes were then polished and coated with Sylgard (Dow Corning Co., Midland, MI). Junction potentials were canceled before forming gigaseals. Once gigaseals were formed, cell-attached or inside-out patch configurations were used to study single-channel currents of capsaicinactivated channels. Channel currents were recorded using a patchclamp amplifier (Axopatch 200B, Axon Instruments, Foster City, CA). The output of the amplifier was filtered at 5 KHz with an 8-pole, low pass Bessel filter built into the amplifier. The filtered output was then digitized, stored on videotape, and imported to a personal computer (IBM Pentium-compatible) to analyze channel-current events. To obtain chart traces the output of the amplifier was filtered at 500 Hz (Frequency Devices, Haverhill, MA) and fed into a thermal array chart recorder (TA-240, Gould, Valley View, OH).
The half-amplitude algorithm in FETCHAN (pCLAMP 8.0, Axon Instruments) was used to detect open events. Channel open probability (P o ) of single channels was calculated according to the equation, I ϭ P o ⅐N⅐i, where I is the mean current over the interval, N is the number of functional channels in the patch, and i is the single-channel current (23, 24) . Channel activity was calculated as N⅐P o , and P o was determined only for patches that contained less than six functional capsaicin-activated channels.
Site-directed Mutagenesis-VR1 cDNA-encoded fragments were amplified by reverse transcription-PCR from cells obtained from adult rat dorsal root ganglia (SuperScript II, Invitrogen). All mutant receptors were generated as previously described (13) . Purified full-length DNAs were subcloned into pSDTF (a generous gift from T. Snutch of British Columbia University) or into pcDNA3 (Invitrogen) for expression in the oocytes of Xenopus laevis or in human embryonic kidney (HEK) 293T cells (ATCC, Manassas, VA) and were confirmed by DNA sequencing using Sequenase 2.0 (Amersham Biosciences).
Oocyte Recording-Templates were linearized with XbaI and transcribed with SP6 RNA polymerase (Megascript, Ambion, Austin, TX). X. laevis oocytes were injected with 5-10 ng of the cRNAs of VR1 or VR1 mutants in 50 nl of diethyl pyrocarbonate-treated water. 2-5 days after injection, 2-electrode voltage clamp recordings were performed (E hold ϭ Ϫ60 mV) to record whole cell currents. The recording chamber was perfused at 2 ml/min with a bath solution containing 96 mM NaCl, 5 mM HEPES, 2 mM KCl, 1.8 mM CaCl 2 , and 1 mM MgCl 2 (pH 7.4) at room temperature, as previously described (13) .
Cell Surface Biotinylation and Immunoblot-Cell surface biotinylation of oocyte membrane was performed as described (25) . Briefly, X. laevis oocytes were injected with 5-10 ng of the cRNAs of VR1 or S502A/T704I mutant. Four days after injection oocytes were incubated with 0.5 mg/ml sulfo-NHS-LC-biotin (Pierce) in ND96 for 30 min at 17°C. After washing with ND96 thoroughly, cells were lysed in the lysis buffer (100 mM NaCl, 20 mM Tris-Cl (pH 7.4), 1% Triton X-100, and protease inhibitors). The clear fraction was reserved for whole-cell lysate after centrifugation at 16,000 g for 2 min at 4°C. Biotinylated membrane proteins were captured with streptavidin-agarose slurry (Sigma) for 3 h at 4°C. Beads were washed with lysis buffer three times and subjected to SDS-PAGE. After transfer to a polyvinylidene difluoride membrane, Western blotting was performed using anti-NVR1 antiserum (diluted 1:1000) (13) . Proteins were visualized using peroxidase-conjugated secondary antibody (Sigma) by enhanced chemiluminescence (ECL, Amersham Biosciences).
Immunohistochemistry-HEK 293T cells transfected with VR1 and its mutant S502A/T704I were seeded on cover glasses coated with poly-L-lysine. After 24 h of incubation, cells were fixed for 10 min in phosphate-buffered saline (PBS) containing 10% formaldehyde at room temperature, washed 3 times with PBS, and permeabilized with PBS containing 0.1%(v/v) Triton X-100 for 5 min at room temperature. The cells were then rinsed with 2% bovine serum albumin for 1 h to block nonspecific protein binding and incubated at 4°C overnight with polyclonal anti-NVR1 (1:1000 dilution) antibody raised in mice. After washing the cells were incubated with fluorescein isothiocyanate-conjugated rabbit anti-mouse IgG (Zymed Laboratories Inc., 1:100 dilution) for 1 h. For nuclear staining cells were incubated with propidium iodide (Sigma). Cells were viewed under a confocal laser scanning microscope (Leica TCS, Wetzlar, Germany).
[ 3 H]Resiniferatoxin (RTX) Binding Assay-HEK 293T cells transfected with wild-type or mutant VR1s were washed with PBS containing 5 mM EDTA and stored at Ϫ80°C until assayed. The binding assay was performed in 96-well filtration plates (Millipore, Billerica, MA) as previously described (6) . In an assay buffer (5 mM KCl, 5.8 mM NaCl, 2 mM MgCl 2 , 320 mM sucrose, 10 mM HEPES (pH 7.4)) containing 0.25 mg/ml bovine serum albumin (Cohn fraction V), 1 ϫ 10 5 cells were loaded in triplicate into wells that had been previously washed with assay buffer and incubated with [ 3 H]RTX (48.0 Ci/mmol, 10 -1000 pM, Amersham Biosciences) in a total reaction volume of 150 l. The microplate-containing samples were gently shaken at 37°C for 1 h. Nonspecific binding was defined as the radioactivity of [ 3 H]RTX in the presence of 1 M nonradioactive RTX (Biomol). To terminate the reaction the microplates were chilled on ice, and ice-cold ␣ 1 -acid glycoprotein (1 mg/well, Sigma) in 50 l of assay buffer was added to each well to eliminate nonspecific binding (26) . The buffer was then allowed to drain immediately. After each wash with a buffer containing 100 g of the ␣ 1 -acid glycoprotein, the plate was suction-dried and finally completely dried by oven heating. Filters of the microplates were punched into a scintillation vial, and the [ 3 H]RTX activity was counted. Binding data were determined using the Hill equation (27) In Vivo Phosphorylation-HEK 293T cells were transfected with the plasmids pcDNA-VR1 or pcDNA-VR1-S502A/T704I using Lipofectamine PLUS (Invitrogen) as instructed by the manufacturer. Approximately 24 h post-transfection, the HEK 293T cells were labeled for 4 h with 0.1 mCi/ml 32 P in phosphate-free minimum essential medium supplemented with nonessential amino acids and sodium pyruvate. After washing with ice-cold PBS the cells were lysed with cold immunoprecipitation buffer containing 0.2 mM sodium orthovanadate, 0.2 mM phenylmethylsulfonyl fluoride, and 0.5% Nonidet P-40 in protease inhibitor mixture (Roche Applied Science). After removing large aggregates, soluble cell lysates were immunoprecipitated with polyclonal anti-VR1 antibody and protein A-agarose. Precipitates were washed 3 times with ice-cold immunoprecipitation buffer and incubated in 2ϫ electrophoresis sample buffer for 10 min at 55°C. Samples were then centrifuged at 4°C for 10 min, separated by 8% SDS-PAGE, and transferred to a polyvinylidene difluoride membrane for immunoblotting and autoradiography. The VR1-transfected cells were also pretreated with 10 M capsaicin for 10 min or with 10 M capsaicin and 10 M FK-506 before immunoprecipitation to induce VR1 desensitization.
Materials-[
3 H]RTX (48.0 Ci/mmol) was purchased from Amersham Biosciences, nonradioactive RTX was from Biomol Research Lab, and human recombinant PKC⑀ was purchased from Biomol Research Lab. The catalytic subunit of PKA (isolated from bovine heart), proteintyrosine kinase (isolated from bovine spleen), and calmodulin-dependent protein kinase II (CaMKII) (isolated from rat brain) were purchased from Sigma. Reagents used in cell culture were purchased from Invitrogen, and all other reagents were from Sigma.
RESULTS
Calcineurin-dependent Desensitization-To determine the molecular events underlying desensitization, whole-cell and single-channel currents activated by capsaicin treatment were recorded from cultured dorsal root ganglion neurons. As shown in Fig. 1 , whole-cell currents (I cap ) were activated (E hold ϭ Ϫ60 mV) but were desensitized with a time constant ( D ) of 34.7 s after prolonged (Ͼ3 min) application of 10 M capsaicin in all 20 dorsal root ganglion cells tested (Fig. 1A) . Strong tachyphylaxis, which is a reduced response to repeated applications of agonist, was also evident (Fig. 1A) . Similarly, the addition of 10 M capsaicin to a bath of the cell-attached patch readily activated single-channel currents (i cap ) at a holding potential of Ϫ60 mV. However, i cap was not sustained and desensitized within about 2 min in all 18 patches tested in the presence of 2 mM Ca 2ϩ in the bath with a D of 30.6 s after capsaicin application. Channel activity (NP o ) 8 s after capsaicin addition was 2.06 Ϯ 0.31, but this reduced to 0.01 Ϯ 0.01 3 min after the addition, which represented a 99 Ϯ 1% (n ϭ 17) reduction (Fig.  1B) . The desensitization of i cap by adding capsaicin to the bath was largely dependent on external Ca 2ϩ , because in a Ca 2ϩ -free bath solution the NP o of i cap reduced only by 20.5 Ϯ 17.1% (n ϭ 16) 3 min after capsaicin application, with a D of 293.2 s (Fig. 1B, inset) . Furthermore, under external Ca 2ϩ -free conditions a 10 mM caffeine challenge (caffeine releases Ca 2ϩ from intracellular Ca 2ϩ stores) also significantly reduced i cap (80 Ϯ 9% reduction in NP o at 5 min, p Ͻ 0.001, n ϭ 12). Because dephosphorylation of the capsaicin-activated channel by calcineurin, a Ca 2ϩ /calmodulin-dependent phosphatase, has been suggested to cause channel desensitization (16), we applied a calcineurin inhibitor, FK-506, to baths containing cell-attached patches. The addition of 1 M FK-506 greatly reduced the desensitization of i cap (n ϭ 10) (Fig. 1, B and C) . Thus, these results suggest that the capsaicin receptor is desensitized by being dephosphorylated by calcineurin.
Recovery of i cap after Desensitization by CaMKII-
The refractoriness of the channel to capsaicin when dephosphorylated by calcineurin further indicates that phosphorylation could in turn recover the channel from desensitization. To test this hypothesis we applied various kinases and their respective cofactors to a bath containing capsaicin receptors that had been previously desensitized. As shown in Fig. 2 , i cap desensitized readily in cell-attached patches (E hold ϭ Ϫ60 mV) after 10 M capsaicin had been added to the bath in the presence of 2 mM Ca 2ϩ . Moreover, desensitization of i cap persisted as long as the inside-out patches endured (ϳ40 min, n ϭ 8). The application of 2 mM ATP alone, a substrate for kinases, did not reactivate desensitized i cap in the majority of patches tested (ϳ70%). However, in ϳ30% of the patches tested, the addition of 2 mM ATP alone recovered i cap from desensitization, presumably due to the presence of kinases in some patch membranes (28, 29) . Therefore, we examined the effects of applying various kinases to patches that did not show i cap recovery from the desensitization induced by 2 mM ATP. As shown in Fig. 2 , the addition of a catalytic subunit of PKA (0.4 M) along with cAMP (100 M) failed to induce the i cap recovery after desensitization. Furthermore, the application of PKC⑀ (4 nM), a specific isoform of PKC known to sensitize VR1 (30, 31) , in combination with its cofactor, 1,2-dioctanoyl glycerol (5 M), failed to reactivate the desensitized receptor. Moreover, treatment with another kinase, protein-tyrosine kinase (1.5 unit/ml), also failed to induce i cap recovery after desensitization. However, when CaMKII (1.5 nM) was added with 10 M calmodulin, i cap recovered from the desensitization by up to ϳ93% of the initial channel activity (Fig. 2, A and B) .
Mutations of VR1 at Its Putative CaMKII Consensus Sites-To confirm further whether VR1 phosphorylation by CaMKII is a prerequisite of channel activation we mutated VR1 at the CaMKII phosphorylation consensus sites and tested for i cap in oocytes expressing mutant VR1. VR1 has five putative phosphorylation sites (i.e. Thr-370, Ser-502, Thr-704, Ser-774, and Ser-800) for "stringent" CaMKII motifs (Hyd-XRXX(T/ S)-Hyd, where X represents any amino acid, and Hyd represents a hydrophobic amino acid residue (32) (Fig. 3A) . Initially, we mutated each CaMKII consensus site. However, unexpectedly, robust current responses to 1 M capsaicin were observed in oocytes expressing each VR1 mutant (Fig. 3, B and C), and these currents were comparable with those of wild-type VR1. This indicates that single mutations at each CaMKII phosphorylation site are insufficient to block I cap . In the case of cystic fibrosis transmembrane conductance regulator chloride channels or other enzymes, a random phosphorylation at more than two CaMKII sites is sufficient for channel activation or enzyme function (33) (34) (35) (36) . To determine whether a random phosphorylation at more than two phosphorylation sites is sufficient for VR1 activation, 10 combinatorial mutations were constructed that disabled two CaMKII phosphorylation sites by replacing Ser and Thr residues with Ala and Ile, respectively. Oocytes expressing nine VR1 mutants with double mutations, such as VR1-T370I/T704I, elicited I cap s with variable magnitudes (Figs. 3, B and C) . However, a VR1 mutant having double mutations at Ser-502 and Thr-704 (VR1-S502A/T704I) completely lost I cap (Fig. 3, B and C) . Similarly, other mutants, VR1-S502A/T704D and VR1-S502D/T704D, that disabled the two phosphorylation sites also failed to respond to capsaicin (Fig. 3C) .
The lack of I cap in VR1-S502A/T704I was not due to a protein channel expression failure because the mutant VR1 exhibited a similar level of expression in cell surface or whole cell lysates of oocytes as that of the wild type VR1 (Fig. 3D) . A high density of VR1 staining was found to be distributed throughout the cytoplasm and in the membrane of VR1-transfected HEK cells, as has been observed by others (4, 37) (Fig. 3D) . Likewise, VR1-S502A/T704I was also found to be expressed in the membrane and in the cytosol of transfected HEK cells (Fig. 3D) . Thus, these results indicate that the phosphorylation by CaMKII is required for the activation of I cap and that phosphorylation at one of the two consensus sites is sufficient and necessary for this activation.
PKA is known to sensitize VR1, which augments I cap in response to repeated applications of capsaicin (38, 39) . VR1 has three putative phosphorylation motifs for PKA, namely, Thr-144, Thr-370, and Ser-502, of which Thr-370 and Ser-502 are common to CaMKII sites (1) . As in the case of mutation at Thr-370 or Ser-502 (Fig. 3C ), mutation at Thr-144 did not affect current activation by capsaicin (data not shown). Even mutation at all of the three PKA phosphorylation sites (VR1-T144I/ T370I/S502A) elicited I cap (Fig. 3, B and C) . Furthermore, be- cause of a recent report which claimed that a putative PKA site, Ser at 116, is important for controlling the desensitization of VR1 (20), we also mutated Ser-116. As reported by Bhave and co-workers (20), we found that mutation at Ser-116 failed to block I cap (Fig. 3B) . Similarly, because Ser-502 and Ser-800, which are common to PKC and CaMKII consensus sites and are known to mediate the sensitizing effect of PKC on VR1 (31), we mutated these two phosphorylation sites to see its effect on activation by capsaicin. As reported by others (31), the VR1-S502A/S800A mutant also elicited a robust I cap (Fig. 3, B and  C) . Thus, these results indicate that disruption of the PKA or of the PKC consensus sites do not affect the activation of VR1 by capsaicin despite their contribution to the sensitization of VR1 by PKA or PKC.
Binding Capacity of Mutant VR1-Because VR1 is a ligandgated channel, the binding of a suitable agonist to VR1 is crucial for channel activation. Therefore, we hypothesized that the inability of VR1-S502A/T704I to activate I cap might be the result of the loss of ligand binding capacity. To test this hypothesis, we examined the binding capacities of wild-type VR1 and of VR1-S502A/T704I for [
3 H]RTX, a potent capsaicin receptor agonist (40) . Fig. 4A 6 cells (n ϭ 3, for triplicate experiments, Hill coefficient ϭ 2.9), respectively, which are comparable with those observed by others (40) . In contrast, HEK cells transfected with VR1-S502A/T704I mutant showed no ability to bind [ 3 H]RTX (Fig. 4B) . Furthermore, when VR1 had been desensitized by 10 M capsaicin for 30 min before the binding assay, VR1-transfected HEK cells exhibited reduced specific binding. This reduction in specific binding after capsaicin treatment was reversed when the HEK cells were co-treated with 10 M FK-506 and 10 M capsaicin (Fig. 4B) . These results suggest that VR1 loses its agonist binding capacity when dephosphorylated by calcineurin, presumably at the CaMKII consensus sites.
In Vivo Phosphorylation of VR1-We investigated whether the phosphorylation of VR1 occurs in vivo, specifically at putative CaMKII sites. HEK cells transfected with wild-type VR1 or VR1-S502A/T704I mutant were incubated in culture medium containing [ 32 P]phosphate. Cell lysates were collected and autoradiographed after being immunoprecipitated with polyclonal VR1 antibody. As shown in Fig. 5 , a control group of cells transfected with VR1 showed a strong signal in the autoradiograph (first lane). When HEK cells expressing wild-type VR1 were pretreated with 10 M capsaicin for 10 min, the immunoprecipitants invariably elicited a weaker signal than the controls (n ϭ 3). In addition, the reduction in the radiolabeled signal was reversed (Fig. 5, third lane) when HEK-VR1 cells were co-incubated with capsaicin and 10 M FK-506. Furthermore, the VR1-S502A/T704I mutant showed a significantly reduced radiolabeled signal (69.5 Ϯ 4.2% reduction, n ϭ 3).
Responses of the VR1-S502A/T704I Mutant to Acid-VR1 is a multimodal sensor, which has the capacity to respond to heat, acid, and vanilloids (1, 4, 13) . Therefore, the activations of VR1 by heat and acid are likely to converge with the mechanistic pathway of vanilloid activation. We therefore transfected HEK cells with VR1 or its mutants to test heat and acid responses. As shown in Fig. 6A , the application of an acidic solution (pH 5.5) evoked two different current responses in VR1-transfected HEK cells, rapidly-activating and -desensitizing current followed by a sustained whole-cell current. The sustained current was VR1-dependent because mock-transfected HEK cells failed to show this current. Moreover, the rapidly activating and desensitizing currents were presumably mediated by acid-sensing channels endogenous to native HEK cells because of their presence in mock-transfected control cells (Fig. 6B) (13, 41) . Unlike the current response of VR1 to capsaicin, the acidevoked currents rarely desensitized or exhibited tachyphylaxis in response to prolonged or repeated applications of acid, even in a Ca 2ϩ -containing bath solution (Fig. 6A ). Furthermore, current response to acid was easily observed in HEK cells transfected with the VR1-S502A/T704I mutant (Fig. 6B) . These results suggest that, unlike activation by vanilloids, activation by acid does not depend on phosphorylation at the two CaMKII consensus sites. We could not record stable heat-evoked currents from HEK cells transfected with wild-type and mutant VR1 and were, thus, unable to determine whether the activation of VR1 by heat requires phosphorylation at two CaMKII phosphorylation sites.
DISCUSSION
In the present study we identified a key kinase and a phosphatase that control the binding of ligands to VR1 and determined the activation or desensitization state of VR1. Desensitization of VR1 was achieved by its dephosphorylation with calcineurin because inhibition by calcineurin slows the desensitization of VR1 and concomitantly increases phosphorylation in vivo. Furthermore, desensitized VR1 regained activity when phosphorylated with CaMKII. Mutation of VR1 at the CaMKII consensus sites blocked the current responses to capsaicin with a concomitant loss of phosphorylation in vivo. Moreover, dephosphorylation at the CaMKII sites appeared to be linked to a reduced ligand binding ability, because the VR1 mutated at the CaMKII sites or desensitized VR1 was found to lose its ability to bind [ 3 H]RTX. The present study demonstrates that the phosphorylation of VR1 is required for its ligand binding, which is a unique way of controlling the activation of ligandgated channels. Thus, unlike the inactivation processes of voltage-gated Na ϩ or shaker K ϩ channels, which are mediated by a ball peptide tethered at the intracellular mouth of the pore (42, 43) , the desensitization of VR1 is achieved only when the channel loses its ability to bind ligand after dephosphorylation (Scheme 1).
Because Ca 2ϩ -signaling controls both CaMKII and calcineurin it seems odd that Ca 2ϩ -signaling can both activate and desensitize i cap . We postulate several mechanisms underlying these two opposing effects. CaMKII and calcineurin may have different activation kinetics (44) . For example, upon Ca 2ϩ influx, after opening VR1, calcineurin activates first and dephosphorylates the channels, leading to channel desensitization. When CaMKII activates slowly and rephosphorylates the channel, the channel regains its ability to bind to its ligands. Another possibility is that the enzymes have different sensitivities to Ca 2ϩ or affinities to calmodulin. Klee (45) shows that calcineurin has a much higher affinity (K D ) for calmodulin than CaMKII (0.1 versus 20 -200 nM, respectively). Therefore, a small increase in intracellular Ca 2ϩ after VR1 has been opened by capsaicin would activate calcineurin first, which would lead to dephosphorylation and, therefore, VR1 desensitization. On the other hand a large increase in Ca 2ϩ would activate CaMKII and phosphorylate VR1. However, the balance between phosphorylation and dephosphorylation could be more complex and involve other mechanisms, such as cross-talk between these two enzyme-signaling pathways (46) .
It appears that two phosphorylation sites are required to control the activation of VR1. However, phosphorylation of both sites is not required, because mutations of a single phosphorylation site allowed the channel to be activated by capsaicin. Capsaicin-sensitive currents were blocked only when both phosphorylation sites were replaced with nonphosphorylatable amino acid residues. It seems highly likely that a random phosphorylation of one of the two consensus sites is sufficient to evoke ligand binding. Therefore, we conclude that the control of VR1 activation by phosphorylation is degenerate. The regula- tion of channel activity by degenerate phosphorylation has also been seen in cystic fibrosis transmembrane conductance regulator chloride channels. Phosphorylation of the regulatory domain of this channel by PKA activates the channel by unplugging the ball-type "R" domain (35, 47) . However, phosphorylation of the R domain is degenerate because the activation of the cystic fibrosis transmembrane conductance regulator chloride channel is accomplished when more than one of the four PKA phosphorylation consensus sites in its R domain is phosphorylated (35) . Regulation of protein activity by degenerate phosphorylation at multiple sites also occurs in the insulin receptor and in the proto-oncogene pp60 c-src (33, 34, 36) .
Like many ion channels the activity of VR1 is controlled by phosphorylation or dephosphorylation. On the other hand the stimulation of the PKC pathway results in an increase in i cap in response to repeated capsaicin applications (8, 48, 49) . Bradykinin and acetylcholine appear to utilize the PKC pathway for augmenting VR1 response (31, 49) . The sensitization of VR1 by PKC requires the phosphorylation of VR1 at both Ser-502 and Ser-800 because mutations at both of these putative PKC sites blocks VR1 sensitization (31) . Similarly, prostaglandin is also known to sensitize i cap in dorsal root ganglion neurons via the PKA pathway (38) . The sensitization of VR1 by PKA requires phosphorylation of all three putative PKA consensus sites, namely, Thr-144, Thr-370, and Ser-502, because mutation of any of these three PKA sites blocks its sensitization to heat (39) . The present study showed that phosphorylation at Ser-502 controls the activation of VR1 by vanilloids. Thus, activation and sensitization mechanisms appear to converge on Ser-502. If this is the case, Ser-502 is a key site for the regulation of the excitability of sensory neurons, because it could be used to control the activation or sensitization of VR1. For example, once Ser-502 is phosphorylated by CaMKII, VR1 is ready to be activated and sensitized if other key sites are phosphorylated by PKA or PKC. When only Thr-704 is phosphorylated, VR1 is activated, but sensitization will not occur until Ser-502 is phosphorylated by either PKC or PKA. Thus, depending on the status of phosphorylation/dephosphorylation at Ser-502 or Thr-704, VR1 becomes either refractory to ligands or susceptible to augmentation by repeated stimuli, which provides a wide range of control over the excitability of sensory neurons in response to phosphorylative/dephosphorylative intracellular stress.
In the present study current response to acid was unaffected by mutating the two CaMKII consensus sites. Furthermore, the current response evoked by acid rarely desensitized or elicited tachyphylaxis after prolonged acid application. These results suggest that, unlike activation by vanilloids, VR1 activation by acid probably does not require the phosphorylation of the CaMKII sites. However, it is less likely that this is the only mechanism controlling desensitization of VR1 activated by acid. Other mechanisms underlying desensitization of VR1 to acid would also be present because Ca 2ϩ -sensitive desensitization of acid-induced current response of VR1 was reported (4, 50) .
In summary, we report that the phosphorylation of VR1 at the two CaMKII sites is a prerequisite for ligand binding. VR1 undergoes desensitization when dephosphorylated at Ser-502 and Thr-704. Thus, phosphorylation/dephosphorylation of VR1 at these consensus sites controls its responsiveness to ligands, which in turn regulates the excitability of sensory neurons for the mediation of inflammatory pain.
